Covidien Announces Enrollment of First Patient in SWIFT PRIME Acute Ischemic Stroke Study

Covidien

today announced the launch of a new study, SWIFT PRIME, which enrolled its first patient at the University at Buffalo. The new multi-center, randomized controlled trial will be one of the largest global studies to examine the adjunctive use of mechanical thrombectomy during the early stages of acute ischemic stroke onset. Covidien's Solitaire FR Revascularization Device will be used in the SWIFT PRIME Study (Photo: Business Wire) Acute ischemic stroke occurs when a clot in a blood vessel blocks blood supply to the brain. According to the American Heart Association, acute ischemic stroke is the leading cause of disability and the fourth most common cause